Our projects

Find out about our current work

We support projects at different stages of the innovation pathway to deliver positive health impact. These are some of the key programmes of work and innovations we are currently supporting. Please get in touch to find out more. We continue to add more projects so do check back regularly.


Opioid deprescribing toolkit

The Eastern AHSN is working in partnership with the ARC and Norfolk and Waveney CCG to improve the quality of life of people living with chronic pain and reducing the harm caused by opioids and other dependence forming medication.
We are working with senior NHS staff and patients to pilot a toolkit for clinicians to aid the deprescribing of opioids in the region.

Measuring fractional exhaled nitric oxide (FeNO) concentration in asthma

FeNO testing is a method of diagnosing asthma by measuring fractional exhaled nitric oxide (FeNO) in the breath of patients suspected of having asthma to improve patient care and outcomes by more effective diagnosis of patients suspected of having asthma. Rollout supported nationally by the AHSN Network as part of the Rapid Uptake Product (RUP) programme.

The National Patient Safety Improvement Programmes (NatPatSIPs)

The National Patient Safety Improvement Programmes (NatPatSIPs) support a culture of safety, continuous learning and sustainable improvement across the healthcare system.

The Mental Health Safety Improvement Programme (MH-SIP)

This programme aims to improve the safety and outcomes of mental health care by reducing unwarranted variation and providing a high-quality healthcare experience.

The Adoption and Spread Safety Improvement Programme (A&S-SIP)

A&S-SIP uses the national patient safety programme’s unique position to both identify and then support the spread and adoption of effective and safe, evidence-based interventions and practice across England.

The Managing Deterioration Safety Improvement Programme (ManDetSIP)

The programme aims to reduce deterioration-associated harm by improving the prevention, identification, escalation and response to physical deterioration, through better system co-ordination and as part of safe and reliable pathways of care.

The Medicines Safety Improvement Programme (MedSIP)

The MedSIP programme addresses the most important causes of severe harm associated with medicines, most of which have been long term challenges to the health and care system.

The Maternity and Neonatal Safety Improvement Programme (MatNeoSIP)

The programme works with all maternity and neonatal providers in our region on a range of key improvement workstreams, aiming to reduce the rate of stillbirths, neonatal death and brain injuries.

The MedTech Funding Mandate (MTFM)

The MedTech Funding Mandate (MTFM) is an NHS Long Term Plan commitment to give patients access to selected NICE approved, cost-efficient technologies more quickly. We are working with suppliers to support trusts to implement the selected innovations, understand local and regional issues and share learnings from NHS organisations who have already implemented them.

Assessing remote monitoring pathways in integrated care systems

This project aims to evaluate how remote monitoring can track a wide range of conditions at home, and who it can help most. Eastern AHSN has partnered with the NIHR Applied Research Collaboration East of England (NIHR ARC EoE) for the programme, with funding from the NHS Insights Prioritisation Programme (NIPP).


Active+ helps increase the confidence of people with long term conditions to monitor and manage their health using wearable technology. Eastern AHSN has supported the roll out of the programme in our region and commissioned an evaluation of the service.


CamAPS FX monitors glucose levels using data provided by a monitor and automatically adjusts the delivery of insulin via a pump, mimicking some of the functions of a healthy pancreas to stabilise glucose levels. It was developed by CamDiab at the University of Cambridge.


CareMonitR enables GP Practices to automate their recall and monitoring activity for patients with long term conditions and standardise care for multimorbidity management. Using intelligent algorithms, the software automatically identifies patients requiring recall and highlights tests required prior to the patient’s review. CareMonitR is a product from CareDoctR.


Cytosponge is a tool to detect Barrett’s Oesophagus – a precursor to oesophageal cancer – which is minimally invasive and can be used in primary care. Using Cytosponge a patient swallows a capsule, about the size of a multi-vitamin pill, which is attached to a cord. When swallowed, the capsule dissolves to release a sponge. The sponge can then be removed by a nurse a few minutes later collecting cells along its passage. These cells are then tested in the laboratory using an accurate method developed by the Fitzgerald Laboratory.

Eastern AHSN is looking at how to support the use of Cytosponge in primary care across the region. 

EarlyCDT Lung

EarlyCDT Lung is a test for the levels of seven autoantibodies to tumour-associated antigens to help improve the detection of lung cancer.

It was created by Oncimmune and Eastern AHSN is looking at supporting a project in primary care across parts of the region.  

Electronic Medicines Optimisation Pathway (EMOP)

Electronic Medicines Optimisation Pathway (EMOP) is reducing medication errors when patients are discharged from hospital by providing community pharmacists with updated medication information.
The tool, also referred to as transfers of care around medicines (TCAM), is a national AHSN Network adoption and spread initiative.


Endoscope-i enables high definition images of the ear, nose and throat (ENT). The system combines the e-i Pro camera app with a bespoke engineered endoscope-i adaptor which fits securely onto an iPhone. This enables a quick diagnostic process and reduced hospital visits.
Eastern AHSN is exploring the development of Endoscope-I in the region, including introducing it to partner organisations with a view to establishing pilots in the region.


ESCAPE-pain classes help people with osteoarthritis manage their condition better and have less pain thanks to an innovative six-week physiotherapist led group exercise and education rehabilitation programme.
This is a national AHSN Network adoption and spread initiative.

Focus ADHD (Attention Deficit Hyperactivity Disorder)

The Focus ADHD programme aims to transform the diagnosis of ADHD across the region. As part of our Focus ADHD programme we use the QbTest which is an objective assessment tool for the assessment of ADHD.
This is a national AHSN Network adoption and spread initiative.

Gut reaction

Eastern AHSN is a key partner in Gut Reaction, the Health Data Research Hub for inflammatory bowel disease (IBD) supported by HDRUK which is led by the NIHR BioResource. The hub will integrate data from multiple sources and create a secure research resource that allows approved researchers to access data, whilst protecting the privacy of individuals.

High-sensitivity troponin testing

Assisting the earlier diagnosis of heart attacks to ensure access to appropriate treatment and avoid unnecessary hospital admissions via a high-sensitivity troponin test that enables healthcare professionals to rule out cardiac arrest within four hours, if the test results are available within three hours of presentation.  

Improving diagnosis of eating disorders

Supporting mental health teams to speed up diagnosis and treatment of eating disorders in young people using the First episode Rapid Early intervention for Eating Disorders (FREED) service.

This is a national AHSN Network adoption and spread initiative. 

Improving lives of people with severe asthma

Eastern AHSN is supporting the adoption of biologic treatments to reduce the number and severity of exacerbations, hospitalisations and deaths.
This innovation is being supported as part of the Rapid Uptake Products (RUP) programme.

Just One Norfolk

JustOneNorfolk.nhs.uk is a trusted multimedia educational initiative (e-learning / website, community forum, helpline, confidential chat service for children) available 24/7, empowering Norfolk parents to achieve the optimum health and wellbeing of their children (0-19 years).

Liberate Pro

Liberate Pro is an app that empowers patients to better manage their conditions whilst reduce the number of clinical appointments needed. It allows a clinician to record their consultation with their patient and send it to them with the further guidance to support understanding of how to manage their condition better.

Little Journey

Reducing anxiety in children through virtual reality

Medic Bleep

Medic Bleep enables hospital and community staff to communicate and collaborate within and across organisations, sharing vital information about patients accurately and safely whilst also save time.
Eastern AHSN supported the evaluation of both a pilot and wider roll out across West Suffolk NHS Foundation Trust.


Medicspot enables contact free consultations in GP surgeries pharmacies and care homes. By using remote diagnostic technology, clinicians can take real-time vitals and perform a remote examination to accurately diagnose and manage patients while minimising infection risks.


MediShout provides a digital platform to integrate all logistical departments, giving clinicians an app to instantly report any issue and track the progress to resolution, while using artificial intelligence (AI) to predict future problems.

Cardiovascular disease (CVD) prevention programme

Improving the detection and management of the high-risk conditions atrial fibrillation (AF), high blood pressure and high cholesterol as well as early diagnosis of familial hypercholesterolaemia.


PINCER is a pharmacist-led IT intervention shown to reduce clinically important errors in general practice prescribing by up to 50%.  It uses software to search GP practice computer systems to identify at-risk patients who are being prescribed drugs commonly associated with medication errors so that actions can be taken to reduce the risk. 

This is a national AHSN Network adoption and spread initiative. 

Placental growth factor (PlGF) based testing

PlGF-based testing can help with clinical risk stratification for women with suspected pre-eclampsia, meaning they can be treated appropriately according to their need, improving both patient experience and outcomes. 

The COVID Oximetry at Home Programme (virtual ward)

COVID Oximetry at Home is an enhanced package of care using pulse oximetry to detect early deterioration of individuals with confirmed or suspected COVID-19.


The Washseat fits over the top of an existing toilet to provide a raised seat and built in washing facility to enable the user to manage their personal hygiene with dignity.

Share your idea

Do you have a great idea that could make a positive health impact?

Get involved